Clinical Trials Directory

Trials / Unknown

UnknownNCT05458778

Detection of Urinary Human Chorionic Gonadotropin (hCG)

Detection of Urinary HCG During The Not Pregnancy and Pregnancy Cycles

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Quanovate Tech Inc. · Industry
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study.

Detailed description

The studies include two parts, which are a lay user study and a urine samples test during the trying to conceive cycle. Part 1: Lay user study Part 2: Detection of hCG in Early Pregnancy Clinical Samples

Conditions

Interventions

TypeNameDescription
DEVICEDaily test with urine by the productWomen perform the hCG test and share the test results

Timeline

Start date
2022-06-29
Primary completion
2023-10-31
Completion
2023-10-31
First posted
2022-07-14
Last updated
2023-05-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05458778. Inclusion in this directory is not an endorsement.

Detection of Urinary Human Chorionic Gonadotropin (hCG) (NCT05458778) · Clinical Trials Directory